Plasma exchange before surgery for left ventricular assist device implantation

Area of Science:

• Cardiology
• Surgical Complications
• Hematology

Background:

• Left ventricular assist device (LVAD) implantation is a critical treatment for end-stage heart failure.
• Hemorrhagic complications and reoperations are common after LVAD implantation due to preoperative coagulopathy.
• Coagulopathy involves prolonged clotting times, platelet dysfunction, and elevated inflammatory markers.

Purpose of the Study:

• To evaluate the impact of preoperative plasma exchange on outcomes in patients undergoing LVAD implantation.
• To compare perioperative mortality and bleeding complications between LVAD patients with and without plasma exchange.

Main Methods:

• Retrospective review of 68 consecutive elective LVAD patients.
• Comparison of outcomes between 35 patients receiving preoperative plasma exchange and 33 control patients.
• Analysis of demographic, clinical, and laboratory data, including coagulation parameters.

Main Results:

• The plasma exchange group showed significantly lower early mortality (0% vs. 18%, P = 0.026).
• Postoperative chest tube drainage was reduced by 33% in the plasma exchange group (P = not significant).
• Blood transfusion requirements were similar between the groups.

Conclusions:

• Preoperative plasma exchange may reduce perioperative mortality in patients undergoing LVAD implantation.
• This intervention could be beneficial for managing coagulopathy in high-risk heart failure patients.